NUR 615 Advanced Pharmacology I Final
Exam Questions With Correct Answers
The |health |care |provider |is |considering |topiramate |therapy |for |a |patient |reporting |chronic |
daily |headaches |that |have |failed |to |be |successfully |managed |on |valproic |acid |and |divalproex. |
What |assessment |data |require |caution |when |prescribing |the |drug |to |this |patient?
a. |The |patient |has |been |diagnosed |with |fatty |liver |disease.
b. |The |patient |has |a |history |of |eczema.
c. |The |patient |has |a |history |of |congestive |heart |failure.
d. |The |patient |is |being |treated |for |atrial |fibrillation. |- |CORRECT |ANSWER✔✔-a. |The |patient |has
|been |diagnosed |with |fatty |liver |disease.
When |prescribing |for |a |new |patient |with |anxiety |and |depression, |the |most |important |
consideration |is:
a. |Advanced |Practice |Nurses |should |always |refer |patients |with |these |disorders |to |a |mental |
health |provider.
b. |Always |take |depressive |drugs |at |bedtime.
c. |Always |assess |your |patient |for |history |of |hypomania |and |mania.
d. |SSRI's |are |not |a |drug |of |choice |for |mixed |anxiety |and |depression |disorders. |- |CORRECT |
ANSWER✔✔-c. |Always |assess |your |patient |for |history |of |hypomania |and |mania.
Prior |to |starting |antidepressants, |patients |should |have |laboratory |testing |to |rule |out:
a. |Diabetes |Mellitus.
b. |Anemia.
c. |Low |estrogen |levels.
d. |Hypothyroidism. |- |CORRECT |ANSWER✔✔-d. |Hypothyroidism.
,An |advanced |practice |nurse |is |considering |second-line |therapy |for |a |patient |who |is |diagnosed |
with |generalized |anxiety |disorder |(GAD). |What |is |the |recommended |treatment |option?
a. |Cognitive-behavioral |therapy |(CBT).
b. |Selective |serotonin |reuptake |inhibitors |(SSRIs).
c. |Serotonin |norepinephrine |reuptake |inhibitors |(SNRIs).
d. |Azapirones |(Buspirone). |- |CORRECT |ANSWER✔✔-d. |Azapirones |(Buspirone).
Which |prescription |is |most |appropriate |for |a |10-year-old |child |being |treated |for |depression?
a. |Fluoxetine.
b. |Venlafaxine.
c. |Paroxetine.
d. |Escitalopram. |- |CORRECT |ANSWER✔✔-a. |Fluoxetine.
A |patient |with |severe |depression |has |been |hospitalized |and |the |advance |practice |nurse |has |
ordered |amitriptyline. |What |common |adverse |effect |will |the |advanced |practice |nurse |monitor |
and |assess |the |patient |for? |(Select |all |that |apply).
a. |Stroke.
b. |Fever.
c. |Myocardial |infarction.
d. |Gynecomastia.
e. |Dry |mouth. |- |CORRECT |ANSWER✔✔-a. |Stroke.
c. |Myocardial |infarction.
e. |Dry |mouth.
A |practitioner |is |explaining |to |a |patient |has |his |antidepressant |acts |to |alleviate |his |symptoms |
of |depression. |Antidepressants |act |by:
a. |Turning |off |associated |receptors.
,b. |Increasing |MAO |enzymes.
c. |Decreasing |norepinephrine |in |the |system.
d. |Inhibiting |the |reuptake |of |the |neurotransmitter. |- |CORRECT |ANSWER✔✔-d. |Inhibiting |the |
reuptake |of |the |neurotransmitter.
Why |is |it |important |to |rule |out |bipolar |disorder |in |a |patient |prescribed |duloxetine?
a. |Treating |both |conditions |with |drug |therapy |at |the |same |time |is |likely |to |result |in |life-
threatening |drug |interactions.
b. |Depression |is |more |severe |in |bipolar |disorder, |ever |when |treating |with |antidepressants.
c. |Bipolar |disorder |is |usually |mild |in |patients |with |depression, |and |it |is |not |important |to |rule |it
|out.
d. |Antidepressant |therapy |without |a |mood |stabilizer |can |lead |to |a |manic |switch |and |worsen |
bipolar |symptoms. |- |CORRECT |ANSWER✔✔-d. |Antidepressant |therapy |without |a |mood |
stabilizer |can |lead |to |a |manic |switch |and |worsen |bipolar |symptoms.
A |patient |has |been |diagnosed |with |restless |leg |syndrome |(RLS) |and |is |being |considered |for |
medication |therapy. |What |medication |should |the |healthcare |provider |consider |as |a |first-line |
therapy |for |this |patient?
a. |Fluoxetine.
b. |Pramipexole.
c. |Ferrous |iron.
d. |Carbidopa-levodopa. |- |CORRECT |ANSWER✔✔-b. |Pramipexole.
Which |is |the |recommended |order |of |treatment |in |antidepressant |therapy?
a. |Atypical |antidepressant |or |TCA, |SSRI, |atypical |antidepressant, |or |TCA.
b. |SSRI, |atypical |antidepressant |then |TCA.
c. |TCA, |SSRI, |atypical |antidepressant, |or |TCA.
d. |Selective |serotonin |reuptake |inhibitor |(SSRI), |tricyclic |antidepressant |(TCA), |atypical |
antidepressant, |or |TCA |- |CORRECT |ANSWER✔✔-b. |SSRI, |atypical |antidepressant |then |TCA.
, A |patient |diagnosed |with |Alzheimer |disease |(AD) |was |started |in |cholinesterase |inhibitor |3 |
months |ago. |Which |assessment |datum |best |indicates |that |the |goals |of |medication |therapy |are
|being |met?
a. |Caregiver |shares |that |patient |appears |quite |content |to |"sit |in |front |of |the |television |most |of
|the |day."
b. |Patient |has |demonstrated |a |minimal |decline |in |short-term |memory |while |long-term |
memory |remains |stable.
c. |Caregiver |reports |that |patient |is |experiencing |less |nausea |than |when |the |medication |was |
first |prescribed.
d. |Patient |continued |to |complete |daily |hygiene |tasks |with |minimal |help |from |caregiver. |- |
CORRECT |ANSWER✔✔-d. |Patient |continued |to |complete |daily |hygiene |tasks |with |minimal |help
|from |caregiver.
A |healthcare |provider |(HCP) |is |discussing |medication |therapy |with |a |patient |experiencing |
symptoms |of |Alzheimer |disease |(AD). |Which |statement |made |by |the |HCP |best |demonstrates |
an |understanding |of |medication |therapy |options?
a. |"Rivastigmine |is |considered |the |'gold |standard' |when |treating |AD."
b. |"It |is |most |advisable |to |initiate |the |medication |therapy |as |soon |as |possible."
c. |"All |medications |have |the |potential |to |cause |side |effects."
d. |"Not |initiating |medication |therapy |is |an |option |you |may |want |to |consider." |- |CORRECT |
ANSWER✔✔-d. |"Not |initiating |medication |therapy |is |an |option |you |may |want |to |consider."
A |patient |who |has |been |on |alprazolam |for |many |years |comes |to |the |office |and |requests |that |
they |need |a |higher |dose. |The |patient |has |no |new |or |increased |triggers |in |their |anxiety. |The |
rationale |for |this |request |is:
a. |The |patient |is |a |drug |seeker.
b. |The |patient |is |a |risk |for |suicide |or |wanting |to |harm |themselves.
c. |The |patient |has |become |tolerant |to |the |drug |therefore |needing |more.
Exam Questions With Correct Answers
The |health |care |provider |is |considering |topiramate |therapy |for |a |patient |reporting |chronic |
daily |headaches |that |have |failed |to |be |successfully |managed |on |valproic |acid |and |divalproex. |
What |assessment |data |require |caution |when |prescribing |the |drug |to |this |patient?
a. |The |patient |has |been |diagnosed |with |fatty |liver |disease.
b. |The |patient |has |a |history |of |eczema.
c. |The |patient |has |a |history |of |congestive |heart |failure.
d. |The |patient |is |being |treated |for |atrial |fibrillation. |- |CORRECT |ANSWER✔✔-a. |The |patient |has
|been |diagnosed |with |fatty |liver |disease.
When |prescribing |for |a |new |patient |with |anxiety |and |depression, |the |most |important |
consideration |is:
a. |Advanced |Practice |Nurses |should |always |refer |patients |with |these |disorders |to |a |mental |
health |provider.
b. |Always |take |depressive |drugs |at |bedtime.
c. |Always |assess |your |patient |for |history |of |hypomania |and |mania.
d. |SSRI's |are |not |a |drug |of |choice |for |mixed |anxiety |and |depression |disorders. |- |CORRECT |
ANSWER✔✔-c. |Always |assess |your |patient |for |history |of |hypomania |and |mania.
Prior |to |starting |antidepressants, |patients |should |have |laboratory |testing |to |rule |out:
a. |Diabetes |Mellitus.
b. |Anemia.
c. |Low |estrogen |levels.
d. |Hypothyroidism. |- |CORRECT |ANSWER✔✔-d. |Hypothyroidism.
,An |advanced |practice |nurse |is |considering |second-line |therapy |for |a |patient |who |is |diagnosed |
with |generalized |anxiety |disorder |(GAD). |What |is |the |recommended |treatment |option?
a. |Cognitive-behavioral |therapy |(CBT).
b. |Selective |serotonin |reuptake |inhibitors |(SSRIs).
c. |Serotonin |norepinephrine |reuptake |inhibitors |(SNRIs).
d. |Azapirones |(Buspirone). |- |CORRECT |ANSWER✔✔-d. |Azapirones |(Buspirone).
Which |prescription |is |most |appropriate |for |a |10-year-old |child |being |treated |for |depression?
a. |Fluoxetine.
b. |Venlafaxine.
c. |Paroxetine.
d. |Escitalopram. |- |CORRECT |ANSWER✔✔-a. |Fluoxetine.
A |patient |with |severe |depression |has |been |hospitalized |and |the |advance |practice |nurse |has |
ordered |amitriptyline. |What |common |adverse |effect |will |the |advanced |practice |nurse |monitor |
and |assess |the |patient |for? |(Select |all |that |apply).
a. |Stroke.
b. |Fever.
c. |Myocardial |infarction.
d. |Gynecomastia.
e. |Dry |mouth. |- |CORRECT |ANSWER✔✔-a. |Stroke.
c. |Myocardial |infarction.
e. |Dry |mouth.
A |practitioner |is |explaining |to |a |patient |has |his |antidepressant |acts |to |alleviate |his |symptoms |
of |depression. |Antidepressants |act |by:
a. |Turning |off |associated |receptors.
,b. |Increasing |MAO |enzymes.
c. |Decreasing |norepinephrine |in |the |system.
d. |Inhibiting |the |reuptake |of |the |neurotransmitter. |- |CORRECT |ANSWER✔✔-d. |Inhibiting |the |
reuptake |of |the |neurotransmitter.
Why |is |it |important |to |rule |out |bipolar |disorder |in |a |patient |prescribed |duloxetine?
a. |Treating |both |conditions |with |drug |therapy |at |the |same |time |is |likely |to |result |in |life-
threatening |drug |interactions.
b. |Depression |is |more |severe |in |bipolar |disorder, |ever |when |treating |with |antidepressants.
c. |Bipolar |disorder |is |usually |mild |in |patients |with |depression, |and |it |is |not |important |to |rule |it
|out.
d. |Antidepressant |therapy |without |a |mood |stabilizer |can |lead |to |a |manic |switch |and |worsen |
bipolar |symptoms. |- |CORRECT |ANSWER✔✔-d. |Antidepressant |therapy |without |a |mood |
stabilizer |can |lead |to |a |manic |switch |and |worsen |bipolar |symptoms.
A |patient |has |been |diagnosed |with |restless |leg |syndrome |(RLS) |and |is |being |considered |for |
medication |therapy. |What |medication |should |the |healthcare |provider |consider |as |a |first-line |
therapy |for |this |patient?
a. |Fluoxetine.
b. |Pramipexole.
c. |Ferrous |iron.
d. |Carbidopa-levodopa. |- |CORRECT |ANSWER✔✔-b. |Pramipexole.
Which |is |the |recommended |order |of |treatment |in |antidepressant |therapy?
a. |Atypical |antidepressant |or |TCA, |SSRI, |atypical |antidepressant, |or |TCA.
b. |SSRI, |atypical |antidepressant |then |TCA.
c. |TCA, |SSRI, |atypical |antidepressant, |or |TCA.
d. |Selective |serotonin |reuptake |inhibitor |(SSRI), |tricyclic |antidepressant |(TCA), |atypical |
antidepressant, |or |TCA |- |CORRECT |ANSWER✔✔-b. |SSRI, |atypical |antidepressant |then |TCA.
, A |patient |diagnosed |with |Alzheimer |disease |(AD) |was |started |in |cholinesterase |inhibitor |3 |
months |ago. |Which |assessment |datum |best |indicates |that |the |goals |of |medication |therapy |are
|being |met?
a. |Caregiver |shares |that |patient |appears |quite |content |to |"sit |in |front |of |the |television |most |of
|the |day."
b. |Patient |has |demonstrated |a |minimal |decline |in |short-term |memory |while |long-term |
memory |remains |stable.
c. |Caregiver |reports |that |patient |is |experiencing |less |nausea |than |when |the |medication |was |
first |prescribed.
d. |Patient |continued |to |complete |daily |hygiene |tasks |with |minimal |help |from |caregiver. |- |
CORRECT |ANSWER✔✔-d. |Patient |continued |to |complete |daily |hygiene |tasks |with |minimal |help
|from |caregiver.
A |healthcare |provider |(HCP) |is |discussing |medication |therapy |with |a |patient |experiencing |
symptoms |of |Alzheimer |disease |(AD). |Which |statement |made |by |the |HCP |best |demonstrates |
an |understanding |of |medication |therapy |options?
a. |"Rivastigmine |is |considered |the |'gold |standard' |when |treating |AD."
b. |"It |is |most |advisable |to |initiate |the |medication |therapy |as |soon |as |possible."
c. |"All |medications |have |the |potential |to |cause |side |effects."
d. |"Not |initiating |medication |therapy |is |an |option |you |may |want |to |consider." |- |CORRECT |
ANSWER✔✔-d. |"Not |initiating |medication |therapy |is |an |option |you |may |want |to |consider."
A |patient |who |has |been |on |alprazolam |for |many |years |comes |to |the |office |and |requests |that |
they |need |a |higher |dose. |The |patient |has |no |new |or |increased |triggers |in |their |anxiety. |The |
rationale |for |this |request |is:
a. |The |patient |is |a |drug |seeker.
b. |The |patient |is |a |risk |for |suicide |or |wanting |to |harm |themselves.
c. |The |patient |has |become |tolerant |to |the |drug |therefore |needing |more.
